The objective of this paper was to prepare and provide resources to pharmacists and other healthcare professionals, enabling them to carry out a critical analysis on drug abuse, acquiring knowledge in several areas that effectively contribute to their personal development in this professional field. Professionals play a crucial role in the reduction and prevention of substances abuse, since they are able to advise patient about illicit drugs, psychotropic medicines and alcohol abuse. There is an urgent need to specialize pharmacists to act in the national public health service and contribute to actions aimed at the surrounding community.

Deep vein thrombosis (DVT) is defined as a thrombotic event involving the deep veins of the lower limbs, popliteal, femoral or iliac veins. DVT is usually accompanied by pulmonary embolism (PE) and venous thromboembolism (VTE) is a term used to specify both possibilities. Thus, this research aimed to carry out a literature review on the use of anticoagulants in hospitalized patients and the role of the pharmacist in guiding the multidisciplinary hospital team on the proper use of drugs. This is a literature review using a qualitative approach, using secondary sources to describe the use of anticoagulants in patients with deep vein thrombosis in the lower limbs. Through the results obtained, it appears that it is up to the pharmacist to instruct the patient about the use of the drug, dose, best time of administration, drug interaction, in addition to healthy habits in non-therapeutic care, being able to make interventions that range from simple signaling from an interaction, to suggestions for alternative therapies or adjustments to the doses prescribed by the physician, when any error or problems related to the therapy are identified. This adjustment must be documented and informed to the prescribing physician, constituting a link between pharmacist, physician and patient.

Anticoagulants are highly efficient drugs, however, their use must be analyzed in terms of pharmacological aspects and therapeutic monitoring is crucial and healthy in cases of venous thromboembolism (VTE). Therefore, this study aims to address the pharmacological aspects and how therapeutic monitoring should be carried out in the use of oral anticoagulants in cases of VTE, analyzing studies on the subject. For this, a literature review was carried out, based on studies dated from 2016 to 2022, from scientific databases of studies on the subject, through a narrative literature review. Ten articles were selected. Among the results, it was seen that the ten articles highlighted in the table emphasize types of oral anticoagulants, which varied according to studies, thus achieving the objectives of the study, demonstrating that the new generation of anticoagulants works to direct a specific step of the coagulation cascade and with the possibility of replacing common pharmacological treatments, bringing greater safety and reduction of side effects. Concluding that anticoagulant therapy was based almost exclusively on the use of heparin, but that over the last few decades, more studies have been developed and new classes of anticoagulant drugs have significantly changed the therapeutic arsenal, bringing greater efficacy and safety in relation to conventional treatment within of the clinical context.

Probabilistic data have shown in recent decades a growth in dissatisfaction with the personal image of individuals, including in Brazil, which has already become the 4th country in the world ranking in the aesthetics market. Given this reality, this study aimed to discuss the role of the pharmaceutical professional in aesthetic health and to present the regulations of the aesthetic pharmacist. Thus, the current legislation, the services provided and the influence of the work of the Pharmacy professional in the field of aesthetics were presented. This is a literature review carried out based on research of scientific articles, legislation and resolutions, already published in Portuguese and English and that deal specifically with the proposed theme. Data collection took place in a database, such as the Virtual Health Library (VHL), Lilacs, Scielo, PubMed, and Google Scholar. The search resulted in 40 articles after using the inclusion and exclusion criteria; 21 articles remained for analysis, interpretation and discussion. In the results, it was evident that in addition to the area of action of the pharmacist in the area of aesthetics is wide, being able to perform, among others, the techniques of electrotherapy, intense pulsed light, cosmetotherapy, chemical and mechanical peeling, and mainly in the evaluation, definition of the procedures and strategies, monitoring and aesthetic evolution. In addition, the aesthetic pharmacist can be the technician in charge of establishments for aesthetic purposes with non-surgical invasive procedures.

JUSTIFICATIVA E OBJETIVOS: A dor é um sintoma frequente nas neoplasias malignas, porém na maioria das vezes o farmacêutico da farmácia hospitalar diante da enorme tarefa burocrática que o afastam do paciente, não tem contribuído significativamente na assistência ao paciente com dor oncológica. O objetivo deste estudo foi propor a inserção o profissional farmacêutico no controle da dor de origem oncológica visando o uso racional e o monitoramento das reações adversas a medicamentos. CONTEÚDO: Para o controle efetivo do quadro álgico, implementação de medidas analgésicas e avaliação da eficácia terapêutica da dor faz-se essencial o uso correto da "Guia para Tratamento da Dor no Câncer" da Organização Mundial de Saúde (OMS), o qual proporciona diretrizes para o controle da dor na maioria dos pacientes com câncer avançado, e ainda, é fundamental o relato da experiência dolorosa do paciente aos profissionais da saúde. CONCLUSÃO: As escalas de mensuração da dor aliadas ao protocolo preconizado pela OMS tem-se mostrado um instrumento essencial para o uso racional de medicamentos. O profissional farmacêutico, além de cumprir com sua atividade corrente, está capacitado para interagir nas equipes multidisciplinares, auxiliando no tratamento álgico de pacientes oncológicos, avaliando o comprimento desse protocolo estabelecido pela OMS no controle da dor.